{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:51Z","timestamp":1792783491042,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key R&D Program of China","award":["2020YFE0201700"],"award-info":[{"award-number":["2020YFE0201700"]}]},{"name":"National Natural Science Foundation of China","award":["82172086"],"award-info":[{"award-number":["82172086"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Frontier Technology Platform Program of Educational Department of Liaoning Province","award":["LJ232410163022"],"award-info":[{"award-number":["LJ232410163022"]}],"id":[{"id":"https:\/\/ror.org\/0022v2454","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13346-026-02075-z","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:50:30Z","timestamp":1773424230000},"page":"3833-3847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ginkgolide B-cyclodextrin inclusion complexes: an encapsulation strategy for improved solubility and aerosol inhalation therapy in bronchial asthma"],"prefix":"10.1007","volume":"16","author":[{"given":"Yuying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingLi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"2075_CR1","doi-asserted-by":"publisher","unstructured":"The Global Asthma Report 2022. int j tuberc lung dis [Internet]. 2022 [cited 2025 Mar 20];26:1\u2013104. https:\/\/doi.org\/10.5588\/ijtld.22.1010.","DOI":"10.5588\/ijtld.22.1010"},{"key":"2075_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2005.12.060","volume":"533","author":"KJ Broadley","year":"2006","unstructured":"Broadley KJ. \u0392-adrenoceptor responses of the airways: for better or worse? Eur J Pharmacol. 2006;533:15\u201327. https:\/\/doi.org\/10.1016\/j.ejphar.2005.12.060.","journal-title":"Eur J Pharmacol"},{"key":"2075_CR3","doi-asserted-by":"publisher","unstructured":"O\u2019Shea O, Stovold E, Cates CJ. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Airways Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2021 [cited 2025 Mar 13];2021. https:\/\/doi.org\/10.1002\/14651858.CD007694.pub3.","DOI":"10.1002\/14651858.CD007694.pub3"},{"issue":"5","key":"2075_CR4","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.21037\/jtd-23-1781","volume":"16","author":"M Scurek","year":"2024","unstructured":"Scurek M, Brat K. A narrative review of theophylline: is there still a place for an old friend? J Thorac Dis. 2024;16(5):3450\u201360. https:\/\/doi.org\/10.21037\/jtd-23-1781.","journal-title":"J Thorac Dis"},{"key":"2075_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0513-4","volume":"17","author":"E Harris","year":"2015","unstructured":"Harris E, Tiganescu A, Tubeuf S, Mackie SL. The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy. Curr Rheumatol Rep. 2015;17:38. https:\/\/doi.org\/10.1007\/s11926-015-0513-4.","journal-title":"Curr Rheumatol Rep"},{"key":"2075_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105189","volume":"160","author":"I Henderson","year":"2020","unstructured":"Henderson I, Caiazzo E, McSharry C, Guzik TJ, Maffia P. Why do some asthma patients respond poorly to glucocorticoid therapy? Pharmacol Res. 2020;160:105189. https:\/\/doi.org\/10.1016\/j.phrs.2020.105189.","journal-title":"Pharmacol Res"},{"key":"2075_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109979","volume":"125","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Lu Y, Jiang X, Hu J, Li R, Liu Y, et al. Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways. Biomed Pharmacother. 2020;125:109979. https:\/\/doi.org\/10.1016\/j.biopha.2020.109979.","journal-title":"Biomed Pharmacother"},{"key":"2075_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/genes15040468","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Peng S, Wang H, Cai X, Wang Q. Review of personalized medicine and pharmacogenomics of anti-cancer compounds and natural products. Genes. 2024;15:468. https:\/\/doi.org\/10.3390\/genes15040468.","journal-title":"Genes"},{"key":"2075_CR9","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.3390\/molecules16097634","volume":"16","author":"X Chu","year":"2011","unstructured":"Chu X, Ci X, He J, Wei M, Yang X, Cao Q, et al. A novel anti-inflammatory role for Ginkgolide B in asthma via inhibition of the ERK\/MAPK signaling pathway. Molecules. 2011;16:7634\u201348. https:\/\/doi.org\/10.3390\/molecules16097634.","journal-title":"Molecules"},{"issue":"1","key":"2075_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-025-00597-0","volume":"12","author":"K Qaderi","year":"2025","unstructured":"Qaderi K, Shahmoradi A, Thyagarajan A, Sahu RP. Impact of targeting the platelet-activating factor and its receptor in cancer treatment. Mil Med Res. 2025;12(1):10. https:\/\/doi.org\/10.1186\/s40779-025-00597-0.","journal-title":"Mil Med Res"},{"key":"2075_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.biopha.2018.10.084","volume":"109","author":"C Lou","year":"2019","unstructured":"Lou C, Lu H, Ma Z, Liu C, Zhang Y. Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR\/NF-\u03baB pathway. Biomed Pharmacother. 2019;109:563\u201372. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.084.","journal-title":"Biomed Pharmacother"},{"key":"2075_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111847","volume":"424","author":"QD Trinh","year":"2026","unstructured":"Trinh QD, Jeong JH, Sharma N, Nguyen YND, Park JH, Pham DT, et al. Critical interplay between PAF receptor and PKC\u03b4 is involved in dopaminergic insult evoked by methamphetamine in mice. Chem Biol Interact. 2026;424:111847. https:\/\/doi.org\/10.1016\/j.cbi.2025.111847.","journal-title":"Chem Biol Interact"},{"key":"2075_CR13","doi-asserted-by":"publisher","unstructured":"Tian Y, Zhou W, Liang H, Qin X. Mechanism of Ginkgolide B regulating Th1\/Th2 balance to improving airway inflammatory response and hyperresponsiveness in asthma model mice: TLR4\/NF-\u03baB pathway. Naunyn-Schmiedeberg\u2019s Arch Pharmacol [Internet]. 2025 [cited 2026 Jan 24]; https:\/\/doi.org\/10.1007\/s00210-025-04492-2.","DOI":"10.1007\/s00210-025-04492-2"},{"issue":"6","key":"2075_CR14","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1007\/s12010-022-03828-5","volume":"194","author":"T-T Niu","year":"2022","unstructured":"Niu T-T, Yin H, Xu B-L, Yang T-T, Li H-Q, Sun Y, et al. Protective effects of Ginkgolide on a cellular model of Alzheimer\u2019s disease via suppression of the NF-\u03baB signaling pathway. Appl Biochem Biotechnol. 2022;194(6):2448\u201364. https:\/\/doi.org\/10.1007\/s12010-022-03828-5.","journal-title":"Appl Biochem Biotechnol"},{"key":"2075_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120376","volume":"598","author":"I Khan","year":"2021","unstructured":"Khan I, Hussein S, Houacine C, Khan Sadozai S, Islam Y, Bnyan R, et al. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers. Int J Pharm. 2021;598:120376. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120376.","journal-title":"Int J Pharm"},{"key":"2075_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121432","volume":"614","author":"M Matuszak","year":"2022","unstructured":"Matuszak M, Ochowiak M, W\u0142odarczak S, Krupi\u0144ska A, Doligalski M. State-of-the-art review of the application and development of various methods of aerosol therapy. Int J Pharm. 2022;614:121432. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121432.","journal-title":"Int J Pharm"},{"key":"2075_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121013","author":"SV Valiulin","year":"2021","unstructured":"Valiulin SV. Aerosol inhalation delivery of cefazolin in mice: pharmacokinetic measurements and antibacterial effect. Int J Pharm. 2021. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121013.","journal-title":"Int J Pharm"},{"issue":"8","key":"2075_CR18","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.apsb.2021.05.015","volume":"11","author":"Y Guo","year":"2021","unstructured":"Guo Y, Bera H, Shi C, Zhang L, Cun D, Yang M. Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines. Acta Pharm Sin B. 2021;11(8):2565\u201384. https:\/\/doi.org\/10.1016\/j.apsb.2021.05.015.","journal-title":"Acta Pharm Sin B"},{"key":"2075_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115146","volume":"204","author":"C Zhang","year":"2024","unstructured":"Zhang C, D\u2019Angelo D, Buttini F, Yang M. Long-acting inhaled medicines: present and future. Adv Drug Deliv Rev. 2024;204:115146. https:\/\/doi.org\/10.1016\/j.addr.2023.115146.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2075_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1039\/D4TB01938E","volume":"13","author":"R Yan","year":"2025","unstructured":"Yan R, Zou C, Yang X, Zhuang W, Huang Y, Zheng X, et al. Nebulized inhalation drug delivery: clinical applications and advancements in research. J Mater Chem B. 2025;13(3):821\u201343. https:\/\/doi.org\/10.1039\/D4TB01938E.","journal-title":"J Mater Chem B"},{"key":"2075_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijpharm.2017.06.084","volume":"529","author":"M M\u00fcnster","year":"2017","unstructured":"M\u00fcnster M, Mohamed-Ahmed AHA, Immohr LI, Schoch C, Schmidt C, Tuleu C, et al. Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations. Int J Pharm. 2017;529:310\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.084.","journal-title":"Int J Pharm"},{"key":"2075_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105758","volume":"160","author":"X Zhou","year":"2021","unstructured":"Zhou X, Li X, Xu J, Cheng Y, Cao F. Latanoprost-loaded cyclodextrin microaggregate suspension eye drops for enhanced bioavailability and stability. Eur J Pharm Sci. 2021;160:105758. https:\/\/doi.org\/10.1016\/j.ejps.2021.105758.","journal-title":"Eur J Pharm Sci"},{"key":"2075_CR23","doi-asserted-by":"publisher","unstructured":"Pose-Vilarnovo B. Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. J Control Release [Internet]. 2003 [cited 2025 Apr 7]; https:\/\/doi.org\/10.1016\/j.jcornel.2003.10.002.","DOI":"10.1016\/j.jcornel.2003.10.002"},{"key":"2075_CR24","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1021\/acsabm.9b00171","volume":"2","author":"A Shukla","year":"2019","unstructured":"Shukla A, Singh AP, Dubey T, Hemalatha S, Maiti P. Third generation cyclodextrin graft with polyurethane embedded in hydrogel for a sustained drug release: complete shrinkage of melanoma. ACS Appl Bio Mater. 2019;2:1762\u201371. https:\/\/doi.org\/10.1021\/acsabm.9b00171.","journal-title":"ACS Appl Bio Mater"},{"key":"2075_CR25","doi-asserted-by":"publisher","first-page":"32352","DOI":"10.1021\/acsami.0c07333","volume":"12","author":"J Tian","year":"2020","unstructured":"Tian J, Xia L, Wu J, Huang B, Cao H, Zhang W. Linear alternating supramolecular photosensitizer for enhanced photodynamic therapy. ACS Appl Mater Interfaces. 2020;12:32352\u20139. https:\/\/doi.org\/10.1021\/acsami.0c07333.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2075_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124755","volume":"665","author":"MT Freeman","year":"2024","unstructured":"Freeman MT, Shen J, Meenach SA. An aerosol nanocomposite microparticle formulation using rifampicin-cyclodextrin inclusion complexes for the treatment of pulmonary diseases. Int J Pharm. 2024;665:124755. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124755.","journal-title":"Int J Pharm"},{"key":"2075_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092345","volume":"15","author":"\u00c1 Sarabia-Vallejo","year":"2023","unstructured":"Sarabia-Vallejo \u00c1, Caja MDM, Olives AI, Mart\u00edn MA, Men\u00e9ndez JC. Cyclodextrin inclusion complexes for improved drug bioavailability and activity: synthetic and analytical aspects. Pharmaceutics. 2023;15:2345. https:\/\/doi.org\/10.3390\/pharmaceutics15092345.","journal-title":"Pharmaceutics"},{"key":"2075_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104714","volume":"87","author":"X Liu","year":"2023","unstructured":"Liu X, Niu W, Liu J, Cui Z, Li J, Zhang Z, et al. Preparation of \u03b2-cyclodextrin and hydroxypropyl-\u03b2-cyclodextrin inclusion complexes of baicalein and evaluation of their effects on dextran sulfate sodium-induced acute ulcerative colitis in mice. J Drug Deliv Sci Technol. 2023;87:104714. https:\/\/doi.org\/10.1016\/j.jddst.2023.104714.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2075_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijpharm.2015.06.043","volume":"491","author":"F Najlaoui","year":"2015","unstructured":"Najlaoui F, Pigeon P, Abdelkafi Z, Leclerc S, Durand P, Ayeb ME, et al. Phthalimido\u2013ferrocidiphenol cyclodextrin complexes: characterization and anticancer activity. Int J Pharm. 2015;491:323\u201334. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.06.043.","journal-title":"Int J Pharm"},{"key":"2075_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2021.131869","volume":"376","author":"Y Hu","year":"2022","unstructured":"Hu Y, Qiu C, Julian McClements D, Qin Y, Long J, Jiao A, et al. Encapsulation, protection, and delivery of curcumin using succinylated-cyclodextrin systems with strong resistance to environmental and physiological stimuli. Food Chem. 2022;376:131869. https:\/\/doi.org\/10.1016\/j.foodchem.2021.131869.","journal-title":"Food Chem"},{"key":"2075_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119649","volume":"587","author":"H Li","year":"2020","unstructured":"Li H, Zhu J, Wang C, Qin W, Hu X, Tong J, et al. Paeonol loaded cyclodextrin metal-organic framework particles for treatment of acute lung injury via inhalation. Int J Pharm. 2020;587:119649. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119649.","journal-title":"Int J Pharm"},{"key":"2075_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123405","volume":"645","author":"X Ren","year":"2023","unstructured":"Ren X, Yang T, Zhang K, Liu Y, Wang C, Wu L, et al. Cyclodextrin MOFs modified dry powder inhalers quadruple bioavailability of luteolin to ameliorate fibrosing interstitial lung disease. Int J Pharm. 2023;645:123405. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123405.","journal-title":"Int J Pharm"},{"issue":"5","key":"2075_CR33","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01724-x","volume":"21","author":"X Wang","year":"2020","unstructured":"Wang X, Parvathaneni V, Shukla SK, Kanabar DD, Muth A, Gupta V. Cyclodextrin complexation for enhanced stability and non-invasive pulmonary delivery of resveratrol\u2014applications in non-small cell lung cancer treatment. AAPS PharmSciTech. 2020;21(5):183. https:\/\/doi.org\/10.1208\/s12249-020-01724-x.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"2075_CR34","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1021\/acs.molpharmaceut.6b01162","volume":"14","author":"T Zhang","year":"2017","unstructured":"Zhang T, Zhu L, Li M, Hu Y, Zhang E, Jiang Q, et al. Inhalable andrographolide-\u03b2-cyclodextrin inclusion complexes for treatment of Staphylococcus aureus pneumonia by regulating immune responses. Mol Pharm. 2017;14(5):1718\u201325. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b01162.","journal-title":"Mol Pharm"},{"key":"2075_CR35","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02510-1","volume":"24","author":"SM Patil","year":"2023","unstructured":"Patil SM, Barji DS, Chavan T, Patel K, Collazo AJ, Prithipaul V, et al. Solubility enhancement and inhalation delivery of cyclodextrin-based inclusion complex of delamanid for pulmonary tuberculosis treatment. AAPS PharmSciTech. 2023;24:49. https:\/\/doi.org\/10.1208\/s12249-023-02510-1.","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"2075_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/polym12102336","volume":"12","author":"L Ren","year":"2020","unstructured":"Ren L, Yang X, Guo W, Wang J, Chen G. Inclusion complex of docetaxel with sulfobutyl ether \u03b2-cyclodextrin: preparation, in vitro cytotoxicity and in vivo safety. Polymers. 2020;12(10):2336. https:\/\/doi.org\/10.3390\/polym12102336.","journal-title":"Polymers"},{"key":"2075_CR37","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1183\/109031936.95.08122104","volume":"8","author":"S Underwood","year":"1995","unstructured":"Underwood S, Foster M, Raeburn D, Bottoms S, Karlsson J. Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Respir J. 1995;8:2104\u201313. https:\/\/doi.org\/10.1183\/109031936.95.08122104.","journal-title":"Eur Respir J"},{"key":"2075_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.colsurfb.2018.09.011","volume":"172","author":"A Nanda","year":"2018","unstructured":"Nanda A, Sahoo RN, Pramanik A, Mohapatra R, Pradhan SK, Thirumurugan A, et al. Drug-in-mucoadhesive type film for ocular anti-inflammatory potential of amlodipine: effect of sulphobutyl-ether-beta-cyclodextrin on permeation and molecular docking characterization. Colloids Surf B Biointerfaces. 2018;172:555\u201364. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.09.011.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2075_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125368","author":"C Li","year":"2025","unstructured":"Li C, Yuan J, Zhang H, Liu N, Wang Z, Zheng A, et al. Taste-masking mechanism of brivaracetam oral solution using cyclodextrin and sodium carboxymethyl cellulose. Int J Pharm. 2025. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125368.","journal-title":"Int J Pharm"},{"key":"2075_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11100521","volume":"11","author":"MG Dogbe","year":"2019","unstructured":"Dogbe MG, Mafilaza AY, Eleut\u00e9rio CV, Cabral-Marques H, Sim\u00f5es S, Gaspar MM. Pharmaceutical benefits of fluticasone propionate association to delivery systems: in vitro and in vivo evaluation. Pharmaceutics. 2019;11:521. https:\/\/doi.org\/10.3390\/pharmaceutics11100521.","journal-title":"Pharmaceutics"},{"key":"2075_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejpb.2022.02.009","volume":"172","author":"K Togami","year":"2022","unstructured":"Togami K, Ogasawara","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02075-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:57:55Z","timestamp":1790603875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02075-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2075"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02075-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}